You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 5.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | n/a | -3.21 | -8.37p | -17.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -6.48 | -12.00p | -5.7 | 0.0 | n/a | n/a | 0.0% |
| Destiny Pharma upbeat on recent study into mupirocin alternative Sharecast News | 18 Oct |
|---|---|
| Destiny Pharma's China partner starts new XF-73 programme Sharecast News | 27 Sep |
| Destiny Pharma reports positive secondary data on 'XF-73' Sharecast News | 02 Aug |
| Destiny Pharma Lancet Report | 21-Jan-22 07:16 |
|---|---|
| Strategy/Company/Ops Update | 17-Jan-22 07:00 |
| Exercise of Options and Total Voting Rights | 21-Dec-21 16:35 |
| Grant of share options | 17-Dec-21 09:46 |
| Directorate Change | 15-Nov-21 14:26 |